Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bosco who wrote (803)	3/20/2000 2:55:00 PM
From: Sten Frelles	Read Replies (2) of 1298

Collateral Thera. (CLTX) 39 1/2 +13 3/4: Company announces positive preliminary results of a double-blinded, placebo-controlled Phase 1/2 clinical trial of the Company's lead non-surgical angiogenic gene therapy product candidate, GENERX, for the treatment of patients with stable exertional angina due to coronary artery disease. Does anybody know if CLTX uses a delivery vehicle covered by CEGE patents? It sure could look like it - check the following page collateralthx.com Why is CEGE left behind the action today?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next